Pathology: non squamous - mNSCLC - L1 - Wild Type (WT); squamous - mNSCLC - L1 - all population;
non squamous - mNSCLC - L1 - Wild Type (WT) | squamous - mNSCLC - L1 - all population | ||
KEYNOTE-189, 2018 | KEYNOTE-407, 2018 | ||
pembrolizumab plus SoC | 2 | T1 | T1 |
placebo plus SoC | 0 | T0 | T0 |